Migraine, Tension-type Headache, and Transformed Migraine
|
|
|
- Beverly Henderson
- 10 years ago
- Views:
Transcription
1 Migraine, Tension-type Headache, and Transformed Migraine Mario F. P. Peres, MD, PhD, Andre Leite Gonçalves, MD, and Abouch Krymchantowski, MD, MSc, PhD Corresponding author Mario F. P. Peres, MD, PhD Al Joaquim Eugenio de Lima, 881 cj 708, , São Paulo, SP, Brazil. Current Pain and Headache Reports 2007, 11: Current Medicine Group LLC ISSN Copyright 2007 by Current Medicine Group LLC Migraine and tension-type headache (TTH) are highly prevalent primary headaches that remain underdiagnosed and undertreated in clinical practice. The similarities and differences between migraine and TTH may impose diagnostic challenges as well as management difficulties. In addition, the possibility of migraine chronification or transformation in daily or near-daily headache raises the potential level of interaction between pathophysiologic mechanisms of TTH and migraine. The continuum concept is a possible key to the understanding of this association. Future studies are necessary to clarify epidemiology, pathophysiology, and management of these two most prevalent headaches. Introduction Migraine, tension-type headache (TTH), and transformed (chronic) migraine (TM) are common and debilitating disorders. The prevalence may vary worldwide, but population-based studies in adults, applying the International Headache Classification in its revised criteria [1], estimate general headache prevalence approaching 46%, migraine reaching 11%, TTH affecting nearly 42% [2], and chronic daily headache reaching 3% (with an estimated prevalence of 2% for transformed/chronic migraine) [3]. According to the World Health Organization, headache disorders are among the 10 most disabling conditions for men and women, and among the five most disabling conditions for women [4 ]. The Diagnostic Challenge Differentiating a TTH attack from a mild to moderate migraine headache attack, the most common episodic headache types, has long been recognized as a common clinical diagnostic challenge. The misdiagnosis of migraine as TTH and vice versa has potentially significant consequences because it may preclude patients with disabling headaches from receiving appropriate treatment, and therefore, increase the burden. Several aspects may complicate diagnosis: 1) poor description and/or presentation of associated symptoms; 2) the concomitant presence of more than one headache type; and 3) when one or more associated features of one specific headache type are present in the other. The concept of a continuum spectrum between migraine and TTH was initially proposed by Waters in 1973 and has been debated more intensively for more than two decades [5]. Its understanding is essential to the understanding of the possible migraine-tth bridge. One pole is migraine headache, with its characteristics of throbbing head pain, unilateral location, moderate to severe or severe intensity, and associated symptoms of nausea, vomiting, photophobia, and phonophobia; TTH is the other pole of the spectrum, with its features of dull head pain, pressing or tightening quality, bilateral location, mild or moderate severity, and less associated symptoms, with the absence of more than one among those accompanying a migraine attack. In between lies a wide range of clinical pictures, including combinations of one feature or another (Fig. 1). This concept had the support of John Graham, who suggested that migraine sufferers had mechanistically related big headaches (phenotypic migraine); TTHs are considered small headaches (phenotypic TTH) [6]. The classification system for headache disorders has improved substantially in the past years, but we are still far from the ideal. The possibility of a continuum concept with opposed poles has not been adequately addressed in the classification attempts, which were first published in 1964, followed by the first edition of the International Headache Society (IHS) diagnostic criteria, published in 1988 [7]. This was revised and improved more recently, in the second edition, published in 2004 [1]. Headaches that do not fulfill migraine or TTH criteria but have characteristics of one or another type were diagnosed in the 1988 edition as a migrainous disorder. However, it has been changed to probable migraine or probable TTH in the second edition (2004) [1], although
2 450 Tension-type Headache Migraine Throbbing Nausea Photo/phonophobia Severe pain Dull Mild pain Figure 1. Features of the continuum between migraine and tension-type Current Pain headache. and Headache Reports PA Fig pts. W/ 156 pts. D (20 x 13) Author: Peres et al. Editor: Chris Artist: TE an overlap of features still exists because a migraine attack missing features of criteria D (nausea and/or vomiting, photophobia and/or phonophobia) may be diagnosed as both probable migraine or probable TTH. A trend toward lumping headache types, including migraine and TTH, together under the label of mixed headache has been observed in daily clinical practice, but better definition on diagnosis and treatment of this headache type is lacking. TTH diagnosis according to the IHS criteria is based mainly on negative characteristics, whereas migraine is based on positive symptoms. Defining TTH or migraine has to do with the presence (migraine) or the absence (TTH) of specific features, such as photophobia and phonophobia, aggravation by routine activity, nausea and/or vomiting, pulsating or throbbing pain quality, and unilateral location (Table 1). The lack of distinctive features of TTH may contribute to its misdiagnosis as migraine, especially in a mild to moderate attack commonly seen in patients undergoing preventive treatment. Health care providers confronted with a patient who meets some but not all of the diagnostic criteria for more distinct and defined headache types, such as migraine, may fall back on the less specific TTH diagnosis. TTH patients need suffer only mild to moderate headache to meet IHS criteria, whereas patients must suffer a number of clear-cut typical associated symptoms in addition to a moderate to severe headache in order to fulfill the IHS criteria for migraine. Therefore, TTH may be less underdiagnosed than migraine. Increased muscle contraction or tenderness in the head and neck, although not included as a differentiating characteristic of TTH in the IHS diagnostic system, is often thought to be a unique feature of TTH, given its hypothesized muscular etiology. On the other hand, it is commonly thought that migraine is not accompanied by muscle tension or neck pain, but this has not been proven true. Increased resting muscle tension and muscle contraction during the headache attack itself may be greater in migraineurs than in TTH sufferers [8]. In addition, it has Tension-type headache recently been demonstrated that neck pain is present in 75% of migraine attacks [9]. The trigger factors for TTH and migraine are also similar. In a study of 172 patients with the IHS diagnoses of migraine, TTH, or both, the percentage of patients indicating common particular factors as responsible for triggering the attacks did not differ between headache types [10]. In addition to the similarities in their clinical manifestations and precipitants, migraine and TTH share several epidemiologic characteristics that may make the differentiation of the two headache types even more difficult. Migraine and TTH are more prevalent in women than in men, although the female:male ratio is greater for migraine than for TTH. The prevalence of both migraine and TTH peaks in middle age (age years) [11]. It also increases with increasing educational level. Moreover, the frequent co-occurrence of the two entities may render their differential diagnosis more challenging. In a Danish population-based study, 83% of individuals with headaches meeting IHS criteria for migraine also had headaches meeting IHS criteria for TTH [12]. In a Canadian population-based study, 22% of patients with classifiable headaches reported experiencing both migraine and TTH [13]. The correct diagnosis is also affected by a common tendency of physicians to choose either a TTH- or migraine-specific diagnosis. For instance, the threshold for admitting the presence of photophobia or phonophobia in the diagnosis is not clearly established in the IHS classification. Consequently, the different methods of detecting how sound or light may affect the headache patient result in clinical discrepancies during initial evaluation, and therefore, diagnosis. It means specifically that the response may be different than a reply to the standard question: does light or sound bother you during the headache attack? In addition, when a patient has a mild headache fulfilling TTH criteria and a more severe headache with migrainous features, the primary diagnosis may be arbitrary, and the doctor s subjective perception becomes the key in defining which headache type the patient presents, although this is not always a reliable approach to performing a diagnosis. Migraine and TTH: Similar or Distinct Disorders? The similarities between migraine and TTH regarding their clinical manifestations, precipitating factors, and epidemiologic features, as well as the frequent association of both headache types in many patients, have raised questions on their uniqueness. Whether migraine and TTH are distinct or similar disorders has been debated among the headache community for years. The continuum concept suggests that TTH and migraine may represent a single entity in different
3 Migraine, Tension-type Headache, and Transformed Migraine Peres et al. 451 Table 1. Migraine and tension-type headache features Feature Migraine Tension-type headache Throbbing type + _ Severe headache + _ Aggravated by physical activity + _ Nausea/vomiting + _ Photophobia/phonophobia + _ Unilateral headache + _ moments of the same spectrum [14]. However, they may be temporarily distinguished by the severity of the head pain, with TTH on the mild end of the continuum and migraine on the severe end [15,16]. Proponents of the view that migraine and TTH are separate disorders contend that TTH arises from abnormal muscle activity or emotional distress, whereas migraine has underlying neurovascular mechanisms. Migraine Transformation Migraine and TTH are also significantly related when migraine transformation into daily or near-daily headache is considered. The clinical experience in tertiary headache centers demonstrates that many patients have a headache occurring daily or almost daily (more than 15 days/month). These patients commonly have a history of episodic migraine, which evolves over time through a process of transformation (chronification) when headache increases in frequency but loses associated symptoms, which become less severe and even absent. The ultimate typical presentation of transformed migraine is less severe headache without typical migraine features resembling TTH but with superimposed full-blown migraine attacks [17]. The process of transformation is often related to analgesic overuse and rebound headache, as well as psychiatric comorbidity [18,19]. However, there is sharp disagreement on the classification of frequent primary headache disorders, as well as on the appropriate use of the term chronic daily headache. In 1988, when the Headache Classification Committee of the IHS first defined the various headache disorders, the issue of frequent primary headaches was not addressed [7]. The term chronic daily headache refers to the broad group of frequent, daily, or near-daily headaches that last longer than 4 hours and therefore have a different time presentation than the brief headaches such as cluster headache and paroxysmal hemicrania. Chronic TTH was the only term in the 1988 IHS classification system that was related to frequent primary headaches, but this is not the most common presentation of frequent headaches. In addition, most patients who had IHS-defined chronic TTH also had an additional diagnosis, such as migraine with or without aura. Because these daily headaches often evolve from episodic migraine, it seems inappropriate to classify them as a form of TTH. The term transformed migraine or evolutive migraine was first proposed by Mathew et al. [20] and was incorporated into the criteria proposed by Silberstein et al. [21] in Recently, TM has also been called chronic migraine, which is widely used nowadays and was included in the last revision of the International Classification of Headache Disorders, coded as 1.5.1, under the group complications of migraine 1.5 [1]. The general group of the chronic daily headaches is defined as headache attacks occurring more than 15 days a month and lasting longer than 4 hours if untreated. It is subdivided into four different entities: 1) chronic migraine, 2) chronic TTH, 3) new daily persistent headache, and 4) hemicrania continua. Each of these disorders may occur with or without analgesic overuse. Secondary headache disorders (such as brain tumor or sinus disease) must be excluded. The current IHS criteria for chronic migraine differ from the criteria proposed for TM by Silberstein et al. [21] in Its case definition comprises migraine headaches that occur for more than 15 days per month for more than 3 months and does not require the transformation period from an episodic form. The operational limitation is when acute or symptomatic medication (SM) is used for more than 10 days (for triptans, ergotamines, and opioids) or 15 days (simple analgesics) per month for more than 3 months. When it is observed, the diagnoses of probable chronic migraine (1.6.5) and probable medication overuse headache (8.2.7) have to be carried out until the acute medication overuse stops for 2 months and the headaches subside and/or reassume the previous pattern of episodic presentation. This is unethical and impractical because one should not propose solely washout for patients with debilitating severe headaches that commonly present rebound and need frequent doses of SM until a treatment is started. Therefore, starting a migraine-preventive treatment should always be the rule and the ethical and humanistic approach. However, this impedes the accomplishment of the proposed diagnosis, and one must stick with the IHS 2004 probable chronic migraine or medication overuse diagnosis for an unbearable suffering time for the patient. Moreover, in order to carry out the medication overuse headache diagnosis, the current criteria also state that at least one of the following must be present: 1) bilateral pain, 2) non-throbbing type, and 3) mild
4 452 Tension-type Headache to moderate severity. In addition, the previous pattern of episodic headache has to be presented after SM withdrawal, which is not always observed due to comorbidity maintaining the chronic presentation pattern. Therefore, further studies are necessary to improve the diagnostic criteria for chronic migraine and its relationship with SM overuse. This has been tried with the new appendix of the International Classification of Headache Disorders-2. It is now recommended that the medication overuse headache diagnosis no longer require improvement after discontinuation of medication overuse but be applied to patients even if they have a primary headache plus ongoing medication overuse, defined previously (ie, 10 days or more of intake of triptans, ergot alkaloids, mixed analgesics, or opioids, and 15 days or more of analgesics/nsaids, or the combined use of more than one substance). If these new criteria for chronic migraine and medication overuse headache prove useful in future testing, either in clinical or research settings, they should be included in a future revised version of International Classification of Headache Disorders-2. TM/Chronic Migraine: Disease Progression The concept of disease progression in migraine has been recently considered after the publication of a neuroimaging study of Dutch adults aged 30 to 60 years. It showed that male patients who had migraine with aura were at an increased risk for posterior circulation infarct [22 ]. Additionally, women with migraine with or without aura were at a higher risk for deep white-matter lesions, compared with controls. The white-matter lesions increased over time with the increasing of attack frequency, possibly suggesting progression of the disease. Another finding, which may suggest disease progression, comes from an elegant study by Welch et al. [23], who demonstrated abnormal deposition of non-heme iron occurring in the periaqueductal gray area in patients with migraine and chronic migraine. Moreover, in a longitudinal population epidemiologic study carried out over the course of 1 year, 3% of individuals with episodic headache (headache frequency from days/year) progressed to chronic daily headache (episode frequency > 180 days/ year). The authors concluded that the incidence of chronic daily headache in patients with episodic headache is 3% per year [24]. In other study, 532 patients with episodic migraine (< 15 days/month) were followed for 1 year; 64 patients (14%) developed chronic daily headache. Despite its clinical relevance, the evidence for the existence of risk factors for migraine progression is still limited. The prevalence of chronic daily headache has been reported to decrease slightly with age and to be higher in women (OR = 1.65; 1.3 2) as well as in divorced, separated, or widowed individuals (OR = 1.5; ). Social risk factors have also been described. The risk of chronic daily headache in individuals with less than high school education was threefold that of a college-educated sample (OR = 3.56; ). Chronic daily headache was also associated with a self-reported diagnosis of arthritis (OR = 2.5; ), diabetes (OR = 1.51; ), previous head trauma, and medication overuse. The highest risk factor described for development of chronic daily headache was obesity (OR = 5.53; ) [25 ]. Psychiatric comorbidity may also play an important role in migraine transformation [26 ]. A study comparing migraine with medication overuse headache found that there was an excess risk for suffering from mood and anxiety disorders associated with use of psychoactive substances [27]. In addition, psychiatric disorders occurred significantly more often before rather than after the transformation from migraine to medication overuse headache [28 ]. Conclusions Migraine and TTH remain commonly underdiagnosed and undertreated conditions worldwide. The similarities and differences between these two frequent headaches may impose diagnostic and management challenges. The process of migraine chronification or transformation emphasizes the potential for true interaction for sharing pathophysiologic mechanisms, and the continuum concept may represent the key to the understanding of this association. Future epidemiologic studies should clarify this issue and shed light into better ways of approaching these patients and relieving their suffering. References and Recommended Reading Papers of particular interest, published recently, have been highlighted as: Of importance Of major importance 1. Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders. 2d ed. Cephalalgia 2004, 24(Suppl 1): Lipton RB, Goadsby P, Silberstein SD: Classification and epidemiology of headache. Clin Cornerstone 1999, 1: Pascual J, Colas R, Castillo J: Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001, 5: Stovner L, Hagen K, Jensen R, et al.: The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27: A worldwide documentation of headache burden, this article is a good reference for migraine and TTH prevalences in different countries. 5. Featherstone HJ: Migraine and muscle contraction headaches: a continuum. Headache 1985, 25: Spierings EL: Migraine, big and small. Headache 2001, 41: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1998, 8(Suppl 7): Bakal DA, Kaganov JA: Muscle contraction and migraine headache: psychophysiologic comparison. Headache 1977, 17: Kaniecki RG: Migraine and tension-type headache: an assessment of challenges in diagnosis. Neurology 2002, 58:S15 S20.
5 Migraine, Tension-type Headache, and Transformed Migraine Peres et al Scharff L, Turk DC, Marcus DA: Triggers of headache episodes and coping responses of headache diagnostic groups. Headache 1995, 35: Lipton RB, Bigal ME: The epidemiology of migraine. Am J Med 2005, 118(Suppl 1):3S 10S. 12. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R: Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol 2005, 161: Pryse-Phillips W, Findlay H, Tugwell P, et al.: A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992, 19: Blumenthal HJ, Rapoport AM: The clinical spectrum of migraine. Med Clin North Am 2001, 85: Nelson CF: The tension headache, migraine headache continuum: a hypothesis. J Manipulative Physiol Ther 1994, 17: Young WB, Peres MF, Rozen TD: Modular headache theory. Cephalalgia 2001, 21: Krymchantowski AV, Moreira PF: Clinical presentation of transformed migraine: possible differences among male and female patients. Cephalalgia 2001, 21: Mathew NT, Reuveni U, Perez F: Transformed or evolutive migraine. Headache 1987, 27: Saper JR: Chronic daily headache: a clinician s perspective. Headache 2002, 42: Mathew NT, Stubits E, Nigam MP: Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982, 22: Silberstein SD, Lipton RB, Sliwinski M: Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996, 47: Kruit MC, Launer LJ, Ferrari MD, van Buchem MA: Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005, 128: After this study, migraine started to be considered potentially as a progressive disorder; migraine with aura patients had more white matter lesions in the posterior circulation. 23. Welch KM, Nagesh V, Aurora SK, Gelman N: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001, 41: Scher AI, Stewart WF, Liberman J, Lipton RB: Prevalence of frequent headache in a population sample. Headache 1998, 38: Bigal ME, Lipton RB: Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006, 67: Interesting study looking at obesity as a factor for headache chronification. 26. Mercante JP, Peres MF, Guendler V, et al.: Depression in chronic migraine: severity and clinical features. Arq Neuropsiquiatr 2005, 63: A clinical sample of chronic migraine patients that shows increased and significant depression rates. 27. Merikangas KR, Stevens DE: Comorbidity of migraine and psychiatric disorders. Neurol Clin 1997, 15: Radat F, Creac h C, Swendsen JD, et al.: Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005, 25: This study supports psychiatric comorbidity as a chronification factor in primary headaches.
New daily persistent headache in the paediatric population
doi:10.1111/j.1468-2982.2008.01647.x New daily persistent headache in the paediatric population E Kung 1, SJ Tepper 2, AM Rapoport 3, FD Sheftell 4 & ME Bigal 1,5 1 Department of Neurology, Albert Einstein
New appendix criteria open for a broader concept of chronic migraine
Blackwell Publishing LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 20062006266742746Original ArticleA broader concept of chronic migrainej Olesen et al. BRIEF REPORT New appendix criteria open
Frequent headache is defined as headaches 15 days/month and daily. Course of Frequent/Daily Headache in the General Population and in Medical Practice
DISEASE STATE REVIEW Course of Frequent/Daily Headache in the General Population and in Medical Practice Egilius L.H. Spierings, MD, PhD, Willem K.P. Mutsaerts, MSc Department of Neurology, Brigham and
None related to the presentation Grants to conduct clinical trials from:
Chronic Daily Headache Bassel F. Shneker, MD, MBA Associate Professor Vice Chair, OSU Neurology The Ohio State University Wexner Medical Center Financial Disclosures None related to the presentation Grants
Classification of Chronic Headache
Chronic Headache Classification of Chronic Headache JMAJ 47(3): 112 117, 2004 Mitsunori MORIMATSU Professor, Department of Neurology and Clinical Neuroscience, Yamaguchi University School of Medicine Abstract:
One Day at a Time: When Headaches Become Chronic. Robert Shapiro, MD, PhD
One Day at a Time: When Headaches Become Chronic Robert Shapiro, MD, PhD Disclosures Scientific/Medical Advisory Boards (since 10/12) Transcept Pharmaceuticals Chronic Headaches: Overview What is a chronic
Chronic daily headache
Chronic daily headache Chronic daily headache (CDH) is defined as any headache syndrome affecting more than half of the month, i.e. a headache on more than 15 days per month. It is also known as daily
When the Pain Won t Stop: Managing Chronic Daily Headache
When the Pain Won t Stop: Managing Chronic Daily Headache Arnolda Eloff, MB, ChB, Mmed Presented at the University of Calgary s Wednesday Evening Course Program, Calgary, Alberta. Copyright Chronic daily
HEADACHES IN CHILDREN AND ADOLESCENTS. Brian D. Ryals, M.D.
HEADACHES IN CHILDREN AND ADOLESCENTS Brian D. Ryals, M.D. Frequency and Type of Headaches in Schoolchildren 8993 children age 7-15 in Sweden Migraine in 4% Frequent Nonmigrainous in 7% Infrequent Nonmigrainous
Sinus Headache vs. Migraine
Sinus Headache vs. Migraine John M. DelGaudio, MD, FACS Professor and Vice Chair Chief of Rhinology and Sinus Surgery Department of Otolaryngology Emory University School of Medicine 1 Sinus Headache Problems
HEADACHE. as. MUDr. Rudolf Černý, CSc. doc. MUDr. Petr Marusič, Ph.D.
HEADACHE as. MUDr. Rudolf Černý, CSc. doc. MUDr. Petr Marusič, Ph.D. Dpt. of Neurology Charles University in Prague, 2nd Faculty of Medicine Motol University Hospital History of headache 1200 years B.C.
Headaches and Kids. Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital
Headaches and Kids Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital Overview Headache classifications and diagnosis Address common headache
Neurovascular Orofacial Pain. Orofacial pain of potential neurovascular origin may mimic odontogenic pain to the extent that
Neurovascular Orofacial Pain Introduction Orofacial pain of potential neurovascular origin may mimic odontogenic pain to the extent that a large population of patients with migraine and trigeminal autonomic
Natural Modality in the Treatment of Primary Headaches. William S. Mihin, D.C. Catharine Helms, M.S. Michelle M. Anderson, M.S.N., F.N.P.
Natural Modality in the Treatment of Primary Headaches William S. Mihin, D.C. Catharine Helms, M.S. Michelle M. Anderson, M.S.N., F.N.P. Abstract Headaches are both a prevalent and disabling condition.
Headaches in Children
Children s s Hospital Headaches in Children Manikum Moodley, MD, FRCP Section of Pediatric Neurology The Cleveland Clinic Foundation Introduction Headaches are common in children Most headaches are benign
Tension-type headache Non-pharmacological and pharmacological treatment
Danish Headache Center Tension-type headache Non-pharmacological and pharmacological treatment Lars Bendtsen Associate professor, MD, PhD, Dr Med Sci Danish Headache Center, Department of Neurology Glostrup
There are two different types of migraines: migraines without aura and migraines with aura.
What is migraine? A migraine is a relatively common medical condition that can severely affect the quality of life of the sufferer and his or her family and friends. 1 Almost 8% of Canadians over the age
Guidance for Industry Migraine: Developing Drugs for Acute Treatment
Guidance for Industry Migraine: Developing Drugs for Acute Treatment DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
Tension Type Headaches
Tension Type Headaches Research Review by : Dr. Ian MacIntyre Physiotherapy for tension-type Headache: A Controlled Study P. Torelli, R. Jenson, J. Olsen: Cephalalgia, 2004, 24, 29-36 Tension-type headache
Headaches in Children How to Manage Difficult Headaches
Headaches in Children How to Manage Difficult Headaches Peter Procopis Childhood headaches Differential diagnosis Migraine Psychological Raised Pressure Childhood headaches Other causes: Constitutional
The Chronification of Migraine
The Chronification of Migraine Jennifer Bickel, MD Medical Director, Comprehensive Headache Clinic Children s Mercy Hospital Division of Neurology Associate Professor of Pediatrics University of Missouri-Kansas
Post Traumatic and other Headache Syndromes. Danielle L. Erb, MD Brain Rehabilitation Medicine, LLC Brain Injury Rehab Center, PRA
Post Traumatic and other Headache Syndromes Danielle L. Erb, MD Brain Rehabilitation Medicine, LLC Brain Injury Rehab Center, PRA Over 45 million Americans have chronic, recurring headaches 62% of these
Differential Diagnosis of Chronic Headache
Chronic Headache Differential Diagnosis of Chronic Headache JMAJ 47(3): 118 123, 2004 Koichi HIRATA Professor, Department of Neurology, Dokkyo University School of Medicine Abstract: Headache is one of
doi:10.1111/j.1468-2982.2009.01913.x
doi:10.1111/j.1468-2982.2009.01913.x Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology studyceph_1913 1..9
Differential Diagnosis of Craniofacial Pain
1. Differential Diagnosis of Craniofacial Pain 2. Headache Page - 1 3. International Headache Society International Classification... 4. The Primary Headaches (1-4) Page - 2 5. The Secondary Headaches
Evaluation of Headache Syndromes and Migraine
Evaluation of Headache Syndromes and Migraine Sonja Potrebic MD PhD Department of Neurology Los Angeles Kaiser Objectives 1) Identify the diagnostic features of migraine Differentiate from sinusitis 2)
HEADACHES AND THE THIRD OCCIPITAL NERVE
HEADACHES AND THE THIRD OCCIPITAL NERVE Edward Babigumira M.D. FAAPMR. Interventional Pain Management, Lincoln. B. Pain Clinic, Ltd. Diplomate ABPMR. Board Certified Pain Medicine No disclosures Disclosure
Tension-type headache Non-pharmacological and pharmacological treatment
Danish Headache Center Tension-type headache Non-pharmacological and pharmacological treatment Lars Bendtsen Associate professor, MD, PhD, Dr Med Sci Danish Headache Center, Department of Neurology Glostrup
Breaking the cycle of medication overuse headache
REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will recognize the risk of developing medication overuse headache with increasing use of medications to treat acute migraine Stewart J. Tepper, MD * Center
Headaches + Facial pain
Headaches + Facial pain Introduction: Each of us experienced sporadically/ chronically headache 40% worldwide population suffers with severe, disabling headache at least annually Common ailment Presenting
03/20/12. Recognize the right of patients to appropriate assessment and management of pain
Narcotic Bowel Syndrome Alvin Zfass M.D. M.D. Professor of Medicine Toufic Kachaamy M.D. GI Fellow Chronic Pain 110 million Americans suffer from chronic pain according to the NIH Cost of untreated t or
SIGN. Diagnosis and management of headache in adults. Quick Reference Guide. Scottish Intercollegiate Guidelines Network
SIGN Scottish Intercollegiate Guidelines Network 107 iagnosis and management of headache in adults Quick Reference Guide November 2008 opies of all SIGN guidelines are available online at www.sign.ac.uk
Spine University s Guide to Neuroplasticity and Chronic Pain
Spine University s Guide to Neuroplasticity and Chronic Pain 2 Introduction Neuroplasticity is also called Brain Plasticity. Neuroplasticity is the ability of your brain to reorganize neural (nerve) pathways
Botulinum toxin in the treatment of chronic migraine. Gregory P. Hanes, MD Neuroscience Summit 5/14/15
Botulinum toxin in the treatment of chronic migraine Gregory P. Hanes, MD Neuroscience Summit 5/14/15 Primary Headache Disorders: Frequency Classification After Secondary Causes Are Ruled Out Short-Duration
2.1 Who first described NMO?
History & Discovery 54 2 History & Discovery 2.1 Who first described NMO? 2.2 What is the difference between NMO and Multiple Sclerosis? 2.3 How common is NMO? 2.4 Who is affected by NMO? 2.1 Who first
What is chronic daily headache? Information for patients Neurology
What is chronic daily headache? Information for patients Neurology What is chronic daily headache (CDH)? Chronic daily headache (CDH) is the term used when a person has a headache on 15 days a month or
Serious Mental Illness: Symptoms, Treatment and Causes of Relapse
Serious Mental Illness: Symptoms, Treatment and Causes of Relapse Bipolar Disorder, Schizophrenia and Schizoaffective Disorder Symptoms and Prevalence of Bipolar Disorder Bipolar disorder, formerly known
Chronic Daily Headache and Chronic Migraine
Chronic Daily Headache and Chronic Migraine 1 CHRONIC DAILY HEADACHE Objectives Define chronic daily headache Distinguish chronic migraine Review new IHS classification Review suspected mechanisms Review
WAT ALS HOOFDPIJN CHRONISCH WORDT? Prof Jan Versijpt, MD PhD Kliniek voor Hoofd- en Aangezichtspijn Neurologie, UZ Brussel
WAT ALS HOOFDPIJN CHRONISCH WORDT? Prof Jan Versijpt, MD PhD Kliniek voor Hoofd- en Aangezichtspijn Neurologie, UZ Brussel Stovner, IHC 2009 New daily persistent headache Primair = dagelijkse and continue
Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas
Billing and Coding in Neurology and Headache Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas CPT Codes vs. ICD Codes Category
Chronic Daily Headache
The new england journal of medicine clinical practice Chronic Daily Headache David W. Dodick, M.D. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting
Cervicogenic Headaches
Cervicogenic Headaches Definition/Description Cervicogenic headaches refer to headache type sensations felt in the head and/face that originates from the neck, most commonly the upper cervical zygapophyseal
New Daily Persistent Headaches in Adolescents
New Daily Persistent Headaches in Adolescents Herbert G. Markley M.D., FAAN, FAHS New England Regional Headache Center University of Massachusetts Medical School Worcester, MA Q. My daughter, who is about
Toothaches of Non-dental Origin
Toothaches of Non-dental Origin This brochure is produced by the American Academy of Orofacial Pain The American Academy of Orofacial Pain is an organization of health care professionals dedicated to alleviating
Menstrual Migraine: Case Studies of Women with Estrogen-Related Headaches. Susan L. Hutchinson, MD; Stephen D. Silberstein, MD, FACP
2008 the Authors Journal compilation 2008 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2008.01311.x Published by Wiley Periodicals, Inc. Research Submission Menstrual Migraine: Case
Botulinum Toxin in the Treatment of Chronic Migraine
Botulinum Toin in the Treatment of Chronic Migraine ERIC L. FRY, MD ASSOCIATE PROFESSOR OF OPHTHALMOLOGY UNIVERSITY OF KANSAS FRY EYE ASSOCIATES, GARDEN CITY, KS History of Botulinum Toin Justinus Kerner,
Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998
Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles
Migraine The Problem: Common Symptoms:
Migraine The Problem: A combination of genetic and environmental factors alter pain mechanisms in your brain Transient changes in brain chemicals such as serotonin and neuropeptides affect the membranes
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults
doi:10.1111/j.1468-2982.2008.01555.x REVIEW Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults S Silberstein 1 (Chairman, USA), P Tfelt-Hansen 2 (Co-Chairman, Denmark),
BOTOX Injection (Onabotulinumtoxin A) for Migraine Headaches [Preauthorization Required]
BOTOX Injection (Onabotulinumtoxin A) for Migraine Headaches [Preauthorization Required] Medical Policy: MP-RX-01-11 Original Effective Date: March 24, 2011 Reviewed: Revised: This policy applies to products
Adult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention
Adult with headache Problem-specific video guides to diagnosing patients and helping them with management and prevention London Strategic Clinical Networks London Neuroscience Strategic Clinical Network
Careful Coding: Headaches
Dynamic Chiropractic March 26, 2012, Vol. 30, Issue 07 Careful Coding: Headaches By K. Jeffrey Miller, DC, DABCO and Ray Tuck, DC Because s are among the most common reasons for seeking chiropractic care,
National Hospital for Neurology and Neurosurgery. Migraine associated dizziness Department of Neuro-otology
National Hospital for Neurology and Neurosurgery Migraine associated dizziness Department of Neuro-otology If you would like this document in another language or format or if you require the services of
Clinical Practice Guideline for the Management of Headache Disorders in Adults
Clinical Practice Guideline for the Management of Headache Disorders in Adults January 2012 Available Online: www.chiropracticcanada.ca This material was developed by the Guidelines Development Committee
DSM-5: A Comprehensive Overview
1) The original DSM was published in a) 1942 b) 1952 c) 1962 d) 1972 DSM-5: A Comprehensive Overview 2) The DSM provides all the following EXCEPT a) Guidelines for the treatment of identified disorders
NeuroStar TMS Therapy Patient Guide for Treating Depression
NeuroStar TMS Therapy Patient Guide for Treating Depression This NeuroStar TMS Therapy Patient Guide for Treating Depression provides important safety and use information for you to consider about treating
Emergency and inpatient treatment of migraine: An American Headache Society
Emergency and inpatient treatment of migraine: An American Headache Society survey. The objective of this study was to determine the practice preferences of AHS members for acute migraine treatment in
Dr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing
Dr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing Overview Depression is significantly higher among elderly adults receiving home healthcare, particularly among
Headaches. This chapter will discuss:
C H A P T E R Headaches 1 1 Almost everyone gets an occasional headache at some time or another. Some people get frequent headaches. Most people do not worry about headaches and learn to live with them
The essentials of a good headache history
The essentials of a good headache history Shuu?Jiun Wang, MD The Neurological Institute, Taipei Veterans General Hospital National Yang?øMing University School of Medicine Taipei, Taiwan September 21,
Neuroimaging of Headache. Kenneth D. Williams, MD
Neuroimaging of Headache Kenneth D. Williams, MD Disclosures Financial: None Off Label Usage: None Key Points Headache is an extremely common symptom. Structural abnormalities (Primary HA) are rare. Clinical
BOTOX Treatment. for Chronic Migraine. Information for patients and their families. Botulinum Toxin Type A
BOTOX Treatment Botulinum Toxin Type A for Chronic Migraine Information for patients and their families. Is Chronic Migraine the same as Migraine? Chronic Migraine is similar to migraine as sufferers experience
The Application of Migraine Disability Assessment Questionnaire (MIDAS)
Continuing Medical Education 43 The Application of Migraine Disability Assessment Questionnaire () Pei-Hua Hung, Jong-Ling Fuh, and Shuu-Jiun Wang Abstract- Migraine is a recurring and disabling pain disorder
Behavioral and Physical Treatments for Tension-type and Cervicogenic Headache
Evidence Report: Behavioral and Physical Treatments for Tension-type and Cervicogenic Headache Douglas C. McCrory, MD, MHSc Donald B. Penzien, PhD Vic Hasselblad, PhD Rebecca N. Gray, DPhil Duke University
The ICHD III Secondary Headaches
The ICHD III Secondary Headaches ICHD II Morris Levin, MD Professor of Neurology Professor of Psychiatry Dartmouth Medical School Co-Director, Dartmouth Headache Center Hanover, New Hampshire, USA ICHD
Presently, there are no means of preventing bipolar disorder. However, there are ways of preventing future episodes: 1
What is bipolar disorder? There are two main types of bipolar illness: bipolar I and bipolar II. In bipolar I, the symptoms include at least one lifetime episode of mania a period of unusually elevated
Depression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
